Observational Study of Arterial Embolization for Treating Bone Metastases in Adults

What this Trial Is About

Researchers are studying the use of arterial embolization as a minimally invasive treatment for bone metastases. This approach is popular because it may help reduce pain, control the disease locally, and decrease bleeding during surgery with minimal invasiveness. The study is observational and aims to gather data on these outcomes in patients who receive embolization therapy. Participants in this study will undergo arterial embolization targeting bone metastases. The study does not involve randomization or comparison groups, as it observes the effects of this treatment in routine clinical practice. The focus is on patients who are candidates for embolization therapy, including those with single or multiple metastatic sites causing pain or risk of bone fracture. During the study, participants will be evaluated for changes in pain levels using the Visual Analog Scale VAS and improvements in quality of life through the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL questionnaires over one year. Researchers will also measure tumor volume reduction at one year. The study will monitor patients health and quality of life while assessing the impact of embolization on bone metastases over this period.

Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study